Emerging HIFU applications in cancer therapy

References

• Lindstrom PA. Prefrontal ultrasonic irradiation – A substitute for lobotomy. Am Med Assoc Arch Neurol Psychiatry 1954;72:399–425
   PubMedGoogle Scholar
• Fry WJ, Barnard JW, Fry EJ, Krumins RF, Brennan JF. Ultrasonic lesions in the mammalian central nervous system. Science 1955;122(3168):517–8
   PubMed Web of Science ®Google Scholar
• Vaezy S, Shi X, Martin RW, Chi E, Nelson PI, Bailey MR, et al. Real-time visualization of high-intensity focused ultrasound treatment using ultrasound imaging. Ultrasound Med Biol 2001;27:33–42
   PubMed Web of Science ®Google Scholar
• Huang CW, Lien DH, Chen BT, Shieh J, Tsui PH, Chen CS, et al. Ultrasound thermal mapping based on a hybrid method combining cross-correlation and zero-crossing tracking. J Acoust Soc Am 2013;134:1530–40
   PubMed Web of Science ®Google Scholar
• Maleke C, Konofagou EE. Harmonic motion imaging for focused ultrasound (HMIFU): A fully integrated technique for sonication and monitoring of thermal ablation in tissues. Phys Med Biol 2008;53:1773–93
   PubMed Web of Science ®Google Scholar
• Hou GY, Marquet F, Wang S, Konofagou EE. Multi-parametric monitoring and assessment of high-intensity focused ultrasound (HIFU) boiling by harmonic motion imaging for focused ultrasound (HMIFU): An ex vivo feasibility study. Phys Med Biol 2014;59:1121–45
   PubMed Web of Science ®Google Scholar
• De Poorter J, De Wagter C, De Deene Y, Thomsen C, Stahlberg F, Achten E. Noninvasive MRI thermometry with the proton resonance frequency (PRF) method: In vivo results in human muscle. Magn Reson Med 1995;33:74–81
   PubMed Web of Science ®Google Scholar
• Kohler MO, Mougenot C, Quesson B, Enholm J, Le Bail B, Laurent C, et al. Volumetric HIFU ablation under 3D guidance of rapid MRI thermometry. Med Phys 2009;36:3521–35
   PubMed Web of Science ®Google Scholar
• Lin TY, Lee CS, Chen KM, Chen CC. Role of surgery in the treatment of primary carcinoma of the liver: A 31-year experience. Br J Surg 1987;74:839–42
   PubMed Web of Science ®Google Scholar
• Zibari GB, Riche A, Zizzi HC, McMillan RW, Aultman DF, Boykin KN, et al. Surgical and nonsurgical management of primary and metastatic liver tumors. Am Surg 1998;64:211–20, discussion 20–1
   PubMed Web of Science ®Google Scholar
• Lin DY, Lin SM, Liaw YF. Non-surgical treatment of hepatocellular carcinoma. J Gastroenterol Hepatol 1997;12:S319–28
   PubMed Web of Science ®Google Scholar
• Wu F, Wang ZB, Chen WZ, Zhu H, Bai J, Zou JZ, et al. Extracorporeal high intensity focused ultrasound ablation in the treatment of patients with large hepatocellular carcinoma. Ann Surg Oncol 2004;11:1061–9
   PubMed Web of Science ®Google Scholar
• Kennedy JE, Wu F, ter Haar GR, Gleeson FV, Phillips RR, Middleton MR, et al. High-intensity focused ultrasound for the treatment of liver tumours. Ultrasonics 2004;42:931–5
   PubMed Web of Science ®Google Scholar
• Leslie T, Ritchie R, Illing R, Ter Haar G, Phillips R, Middleton M, et al. High-intensity focused ultrasound treatment of liver tumours: Post-treatment MRI correlates well with intra-operative estimates of treatment volume. Br J Radiol 2012;85:1363–70
   PubMed Web of Science ®Google Scholar
• Wu F, Wang ZB, Chen WZ, Zou JZ, Bai J, Zhu H, et al. Advanced hepatocellular carcinoma: Treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization. Radiology 2005;235:659–67
   PubMed Web of Science ®Google Scholar
• Li CX, Wu PH, Fan WJ, Huang JH, Zhang FJ, Zhang L, et al. [Clinical effect of transcatheter arterial chemoembolization combined with high intensity focused ultrasound ablation in treatment of large hepatocellular carcinoma]. Zhonghua Yi Xue Za Zhi 2009;89:754–7
   PubMedGoogle Scholar
• Kim J, Chung DJ, Jung SE, Cho SH, Hahn ST, Lee JM. Therapeutic effect of high-intensity focused ultrasound combined with transarterial chemoembolisation for hepatocellular carcinoma <5 cm: Comparison with transarterial chemoembolisation monotherapy – Preliminary observations. Br J Radiol 2012;85:e940–6
   PubMed Web of Science ®Google Scholar
• Cheung TT, Poon RT, Jenkins CR, Chu FS, Chok KS, Chan AC, et al. Survival analysis of high-intensity focused ultrasound therapy vs transarterial chemoembolization for unresectable hepatocellular carcinomas. Liver Int 2014;34:e136–43
   PubMed Web of Science ®Google Scholar
• Wang S, Yang C, Zhang J, Kong XR, Zhu H, Wu F, et al. First experience of high-intensity focused ultrasound combined with transcatheter arterial embolization as local control for hepatoblastoma. Hepatology 2014;59:170–7
   PubMed Web of Science ®Google Scholar
• Chok KS, Cheung TT, Lo RC, Chu FS, Tsang SH, Chan AC, et al. Pilot study of high-intensity focused ultrasound ablation as a bridging therapy for hepatocellular carcinoma patients wait-listed for liver transplantation. Liver Transpl 2014;20:912–21
   PubMed Web of Science ®Google Scholar
• Illing RO, Kennedy JE, Wu F, ter Haar GR, Protheroe AS, Friend PJ, et al. The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a western population. Br J Cancer 2005;93:890–5
   PubMed Web of Science ®Google Scholar
• Sung HY, Cho SH, Kim JI, Cheung DY, Han JY, Kim JK, et al. High intensity focused ultrasound therapy resulted in a complete response in a patient with advanced gastric cancer with liver metastases: A case report. Eur J Gastroenterol Hepatol 2008;20:707–9
   PubMed Web of Science ®Google Scholar
• Hwang JH, Crum LA. Current status of clinical high-intensity focused ultrasound. 31st Annual International Conference of the IEEE EMBSMinneapolis, Minnesota, USA, September 2-6. Eng Med Biol Soc 2009;2009:130–3
   PubMedGoogle Scholar
• Wijlemans JW, de Greef M, Schubert G, Moonen CT, van den Bosch MA, Ries M. Intrapleural fluid infusion for MR-guided high-intensity focused ultrasound ablation in the liver dome. Acad Radiol 2014. doi:j.acra/j.acra.2014.06.015. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Auboiroux V, Petrusca L, Viallon M, Muller A, Terraz S, Breguet R, et al. Respiratory-gated MRgHIFU in upper abdomen using an MR-compatible in-bore digital camera. Biomed Res Int 2014;2014:421726
   PubMed Web of Science ®Google Scholar
• Celicanin Z, Auboiroux V, Bieri O, Petrusca L, Santini F, Viallon M, et al. Real-time method for motion-compensated MR thermometry and MRgHIFU treatment in abdominal organs. Magn Reson Med 2014;72:1087–95
   PubMed Web of Science ®Google Scholar
• Wu F, Wang ZB, Cao YD, Zhu XQ, Zhu H, Chen WZ, et al. ‘Wide local ablation’ of localized breast cancer using high intensity focused ultrasound. J Surg Oncol 2007;96:130–6
   PubMed Web of Science ®Google Scholar
• Wu F, Wang ZB, Zhu H, Chen WZ, Zou JZ, Bai J, et al. Extracorporeal high intensity focused ultrasound treatment for patients with breast cancer. Breast Cancer Res Treat 2005;92:51–60
   PubMed Web of Science ®Google Scholar
• Furusawa H, Namba K, Nakahara H, Tanaka C, Yasuda Y, Hirabara E, et al. The evolving non-surgical ablation of breast cancer: MR guided focused ultrasound (MRgFUS). Breast Cancer 2007;14:55–8
   PubMedGoogle Scholar
• Huber PE, Jenne JW, Rastert R, Simiantonakis I, Sinn HP, Strittmatter HJ, et al. A new noninvasive approach in breast cancer therapy using magnetic resonance imaging-guided focused ultrasound surgery. Cancer Res 2001;61:8441–7
   PubMed Web of Science ®Google Scholar
• Zippel DB, Papa MZ. The use of MR imaging guided focused ultrasound in breast cancer patients; a preliminary phase one study and review. Breast Cancer 2005;12:32–8
   PubMedGoogle Scholar
• Hynynen K, Pomeroy O, Smith DN, Huber PE, McDannold NJ, Kettenbach J, et al. MR imaging-guided focused ultrasound surgery of fibroadenomas in the breast: A feasibility study. Radiology 2001;219:176–85
   PubMed Web of Science ®Google Scholar
• Napoli A, Anzidei M, Ciolina F, Marotta E, Cavallo Marincola B, Brachetti G, et al. MR-guided high-intensity focused ultrasound: Current status of an emerging technology. Cardiovasc Intervent Radiol 2013;36:1190–203
   PubMed Web of Science ®Google Scholar
• Wong A, Watson KD, Fite BZ, Liu Y, Seo JW, Mahakian LM, et al. Enhanced accumulation of Cu-doxorubicin nanoparticles with MR guided focused ultrasound thermal ablation. Paper presented at the International Symposium on Therapeutic Ultrasound, Las Vegas, NV, 3 April 2014
   Google Scholar
• Faivre J, Forman D, Esteve J, Obradovic M, Sant M. Survival of patients with primary liver cancer, pancreatic cancer and biliary tract cancer in Europe. EUROCARE Working Group. Eur J Cancer 1998;34:S2184–90
   PubMed Web of Science ®Google Scholar
• Nakakura EK, Yeo CJ. Periampullary and pancreatic cancer. In: Blumgart LH, editor. Surgery of the Liver, Biliary Tract and Pancreas. 4th ed. Philadelphia: Saunders; 2007
   Google Scholar
• Xiong LL, Hwang JH, Huang XB, Yao SS, He CJ, Ge XH, et al. Early clinical experience using high intensity focused ultrasound for palliation of inoperable pancreatic cancer. JOP 2009;10:123–9
   PubMedGoogle Scholar
• Wang K, Chen Z, Meng Z, Lin J, Zhou Z, Wang P, et al. Analgesic effect of high intensity focused ultrasound therapy for unresectable pancreatic cancer. Int J Hyperthermia 2011;27:101–7
   PubMed Web of Science ®Google Scholar
• Li PZ, Zhu SH, He W, Zhu LY, Liu SP, Liu Y, et al. High-intensity focused ultrasound treatment for patients with unresectable pancreatic cancer. Hepatobiliary Pancreat Dis Int 2012;11:655–60
   PubMed Web of Science ®Google Scholar
• Orsi F, Zhang L, Arnone P, Orgera G, Bonomo G, Vigna PD, et al. High-intensity focused ultrasound ablation: Effective and safe therapy for solid tumors in difficult locations. Am J Roentgenol 2010;195:W245–52
   PubMed Web of Science ®Google Scholar
• Sung HY, Jung SE, Cho SH, Zhou K, Han JY, Han ST, et al. Long-term outcome of high-intensity focused ultrasound in advanced pancreatic cancer. Pancreas 2011;40:1080–6
   PubMed Web of Science ®Google Scholar
• Zhao H, Yang G, Wang D, Yu X, Zhang Y, Zhu J, et al. Concurrent gemcitabine and high-intensity focused ultrasound therapy in patients with locally advanced pancreatic cancer. Anticancer Drugs 2010;21:447–52
   PubMed Web of Science ®Google Scholar
• Chauffert B, Mornex F, Bonnetain F, Rougier P, Mariette C, Bouche O, et al. Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000–01 FFCD/SFRO study. Ann Oncol 2008;19:1592–9
   PubMed Web of Science ®Google Scholar
• Zhou Y. High-intensity focused ultrasound treatment for advanced pancreatic cancer. Gastroenterol Res Pract 2014;2014:205325
   PubMed Web of Science ®Google Scholar
• Hwang JH, Farr N, Morrison K, Wang Y, Khokhlova T, Ko B, et al. Development of an EUS-guided high-intensity focused ultrasound endoscope. Gastrointestinal Endoscopy 2011;73:AB155
   Google Scholar
• Adams M, Salgaonkar VA, Jones P, Plata JC, Chen HY, Pauly KB, et al. Experimental investigations of an endoluminal ultrasound applicator for MR-guided thermal therapy of pancreatic cancer. Paper presented at the International Symposium on Therapeutic Ultrasound, Las Vegas, NV, 3 April 2014
   Google Scholar
• Farr N, Wang Y, D’Andrea S, Starr F, Lee D, Hwang JH. Hyperthermia triggered drug delivery in pancreatic cancer mouse model using MR-guided focused ultrasound. Paper presented at the International Symposium on Therapeutic Ultrasound, Las Vegas, NV, 3 April 2014
   Google Scholar
• Neesse A, Michl P, Frese KK, Feig C, Cook N, Jacobetz MA, et al. Stromal biology and therapy in pancreatic cancer. Gut 2011;60:861–8
   PubMed Web of Science ®Google Scholar
• Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 2006;12:S6243–9
   PubMed Web of Science ®Google Scholar
• Chow E, Harris K, Fan G, Tsao M, Sze WM. Palliative radiotherapy trials for bone metastases: A systematic review. J Clin Oncol 2007;25:1423–36
   PubMed Web of Science ®Google Scholar
• Huisman M, van den Bosch MA, Wijlemans JW, van Vulpen M, van der Linden YM, Verkooijen HM. Effectiveness of reirradiation for painful bone metastases: A systematic review and meta-analysis. Int J Radiat Oncol Biol Phys 2012;84:8–14
   PubMed Web of Science ®Google Scholar
• Ratasvuori M, Wedin R, Keller J, Nottrott M, Zaikova O, Bergh P, et al. Insight opinion to surgically treated metastatic bone disease: Scandinavian Sarcoma Group Skeletal Metastasis Registry report of 1195 operated skeletal metastasis. Surg Oncol 2013;22:132–8
   PubMed Web of Science ®Google Scholar
• Weiss RJ, Wedin R. Surgery for skeletal metastases in lung cancer. Acta Orthop 2011;82:96–101
   PubMed Web of Science ®Google Scholar
• Callstrom MR, Dupuy DE, Solomon SB, Beres RA, Littrup PJ, Davis KW, et al. Percutaneous image-guided cryoablation of painful metastases involving bone: Multicenter trial. Cancer 2013;119:1033–41
   PubMed Web of Science ®Google Scholar
• Jolesz FA. MRI-guided focused ultrasound surgery. Annu Rev Med 2009;60:417–30
   PubMed Web of Science ®Google Scholar
• Catane R, Beck A, Inbar Y, Rabin T, Shabshin N, Hengst S, et al. MR-guided focused ultrasound surgery (MRgFUS) for the palliation of pain in patients with bone metastases – Preliminary clinical experience. Ann Oncol 2007;18:163–7
   PubMed Web of Science ®Google Scholar
• Liberman B, Gianfelice D, Inbar Y, Beck A, Rabin T, Shabshin N, et al. Pain palliation in patients with bone metastases using MR-guided focused ultrasound surgery: A multicenter study. Ann Surg Oncol 2009;16:140–6
   PubMed Web of Science ®Google Scholar
• Gianfelice D, Gupta C, Kucharczyk W, Bret P, Havill D, Clemons M. Palliative treatment of painful bone metastases with MR imaging-guided focused ultrasound. Radiology 2008;249:355–63
   PubMed Web of Science ®Google Scholar
• Hurwitz MD, Ghanouni P, Kanaev SV, Iozeffi D, Gianfelice D, Fennessy FM, et al. Magnetic resonance-guided focused ultrasound for patients with painful bone metastases: Phase III trial results. J Natl Cancer Inst 2014;106:1–9. doi: 10.1093/jnci/dju082
   Google Scholar
• Li C, Wu P, Zhang L, Fan W, Huang J, Zhang F. Osteosarcoma: Limb salvaging treatment by ultrasonographically guided high-intensity focused ultrasound. Cancer Biol Ther 2009;8:1102–8
   PubMed Web of Science ®Google Scholar
• Chen W, Zhu H, Zhang L, Li K, Su H, Jin C, et al. Primary bone malignancy: Effective treatment with high-intensity focused ultrasound ablation. Radiology 2010;255:967–78
   PubMed Web of Science ®Google Scholar
• Pisters PW, Harrison LB, Leung DH, Woodruff JM, Casper ES, Brennan MF. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol 1996;14:859–68
   PubMed Web of Science ®Google Scholar
• Yang JC, Chang AE, Baker AR, Sindelar WF, Danforth DN, Topalian SL, et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 1998;16:197–203
   PubMed Web of Science ®Google Scholar
• Motamedi D, Learch TJ, Ishimitsu DN, Motamedi K, Katz MD, Brien EW, et al. Thermal ablation of osteoid osteoma: Overview and step-by-step guide. Radiographics 2009;29:2127–41
   PubMed Web of Science ®Google Scholar
• Napoli A, Mastantuono M, Cavallo Marincola B, Anzidei M, Zaccagna F, Moreschini O, et al. Osteoid osteoma: MR-guided focused ultrasound for entirely noninvasive treatment. Radiology 2013;267:514–21
   PubMed Web of Science ®Google Scholar
• Geiger D, Napoli A, Conchiglia A, Gregori LM, Arrigoni F, Bazzocchi A, et al. MR-guided focused ultrasound (MRgFUS) ablation for the treatment of nonspinal osteoid osteoma: A prospective multicenter evaluation. J Bone Joint Surg Am 2014;96:743–51
   PubMed Web of Science ®Google Scholar
• Mullen JT, Delaney TF, Kobayashi WK, Szymonifka J, Yeap BY, Chen YL, et al. Desmoid tumor: Analysis of prognostic factors and outcomes in a surgical series. Ann Surg Oncol 2012;19:4028–35
   PubMed Web of Science ®Google Scholar
• Ballo MT, Zagars GK, Pollack A, Pisters PW, Pollack RA. Desmoid tumor: Prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. J Clin Oncol 1999;17:158–67
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang W, Tang J. Ultrasound-guided high intensity focused ultrasound treatment for extra-abdominal desmoid tumours: Preliminary results. Int J Hyperthermia 2011;27:648–53
   PubMed Web of Science ®Google Scholar
• Ghanouni P, Bitton R, Bucknor M, Butts Pauly K, Avedian R. Treatment of extra-abdominal desmoid tumors using MR guided high intensity focused ultrasound: Preliminary results after five patients. Paper presented at the International Symposium on Therapeutic Ultrasound, Las Vegas, NV, 3 April 2014
   Google Scholar
• Papini E, Pacella CM, Misischi I, Guglielmi R, Bizzarri G, Dossing H, et al. The advent of ultrasound-guided ablation techniques in nodular thyroid disease: Towards a patient-tailored approach. Best Pract Res Clin Endocrinol Metab 2014;28:601–18
   PubMed Web of Science ®Google Scholar
• Iglesias P, Diez JJ. Current treatments in the management of patients with primary hyperparathyroidism. Postgrad Med J 2009;85(999):15–23
   PubMed Web of Science ®Google Scholar
• Esnault O, Franc B, Menegaux F, Rouxel A, De Kerviler E, Bourrier P, et al. High-intensity focused ultrasound ablation of thyroid nodules: First human feasibility study. Thyroid 2011;21:965–73
   PubMed Web of Science ®Google Scholar
• Kovatcheva RD, Vlahov JD, Shinkov AD, Borissova AM, Hwang JH, Arnaud F, et al. High-intensity focused ultrasound to treat primary hyperparathyroidism: A feasibility study in four patients. Am J Roentgenol 2010;195:830–5
   PubMed Web of Science ®Google Scholar
• Cooperberg MR, Mallin K, Ritchey J, Villalta JD, Carroll PR, Kane CJ. Decreasing size at diagnosis of stage 1 renal cell carcinoma: Analysis from the National Cancer Data Base, 1993 to 2004. J Urol 2008;179:2131–5
   PubMed Web of Science ®Google Scholar
• Kane CJ, Mallin K, Ritchey J, Cooperberg MR, Carroll PR. Renal cell cancer stage migration: Analysis of the National Cancer Data Base. Cancer 2008;113:78–83
   PubMed Web of Science ®Google Scholar
• Jayson M, Sanders H. Increased incidence of serendipitously discovered renal cell carcinoma. Urology 1998;51:203–5
   PubMed Web of Science ®Google Scholar
• Heuer R, Gill IS, Guazzoni G, Kirkali Z, Marberger M, Richie JP, et al. A critical analysis of the actual role of minimally invasive surgery and active surveillance for kidney cancer. Eur Urol 2010;57:223–32
   PubMed Web of Science ®Google Scholar
• Porpiglia F, Volpe A, Billia M, Scarpa RM. Laparoscopic versus open partial nephrectomy: Analysis of the current literature. Eur Urol 2008;53:732–42, discussion 42–3
   PubMed Web of Science ®Google Scholar
• Psutka SP, Feldman AS, McDougal WS, McGovern FJ, Mueller P, Gervais DA. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma. Eur Urol 2013;63:486–92
   PubMed Web of Science ®Google Scholar
• Tracy CR, Raman JD, Donnally C, Trimmer CK, Cadeddu JA. Durable oncologic outcomes after radiofrequency ablation: Experience from treating 243 small renal masses over 7.5 years. Cancer 2010;116:3135–42
   PubMed Web of Science ®Google Scholar
• Klingler HC, Susani M, Seip R, Mauermann J, Sanghvi N, Marberger MJ. A novel approach to energy ablative therapy of small renal tumours: Laparoscopic high-intensity focused ultrasound. Eur Urol 2008;53:810–16, discussion 7–8
   PubMed Web of Science ®Google Scholar
• Ritchie RW, Leslie TA, Turner GD, Roberts IS, D’Urso L, Collura D, et al. Laparoscopic high-intensity focused ultrasound for renal tumours: A proof of concept study. BJU Int 2011;107:1290–6
   PubMed Web of Science ®Google Scholar
• Marberger M, Schatzl G, Cranston D, Kennedy JE. Extracorporeal ablation of renal tumours with high-intensity focused ultrasound. BJU Int 2005;95:S52–5
   PubMed Web of Science ®Google Scholar
• Hacker A, Michel MS, Marlinghaus E, Kohrmann KU, Alken P. Extracorporeally induced ablation of renal tissue by high-intensity focused ultrasound. BJU Int 2006;97:779–85
   PubMed Web of Science ®Google Scholar
• Wu F, Wang ZB, Chen WZ, Bai J, Zhu H, Qiao TY. Preliminary experience using high intensity focused ultrasound for the treatment of patients with advanced stage renal malignancy. J Urol 2003;170:2237–40
   PubMed Web of Science ®Google Scholar
• Fry WJ, Mosberg WH Jr, Barnard JW, Fry FJ. Production of focal destructive lesions in the central nervous system with ultrasound. J Neurosurg 1954;11:471–8
   PubMed Web of Science ®Google Scholar
• McDannold N, Clement GT, Black P, Jolesz F, Hynynen K. Transcranial magnetic resonance imaging-guided focused ultrasound surgery of brain tumors: Initial findings in 3 patients. Neurosurgery 2010;66:323–32, discussion 32
   PubMed Web of Science ®Google Scholar
• Jeanmonod D, Werner B, Morel A, Michels L, Zadicario E, Schiff G, et al. Transcranial magnetic resonance imaging-guided focused ultrasound: Noninvasive central lateral thalamotomy for chronic neuropathic pain. Neurosurg Focus 2012;32:E1
   PubMed Web of Science ®Google Scholar
• Martin E, Jeanmonod D, Morel A, Zadicario E, Werner B. High-intensity focused ultrasound for noninvasive functional neurosurgery. Ann Neurol 2009;66:858–61
   PubMed Web of Science ®Google Scholar
• Elias WJ, Huss D, Voss T, Loomba J, Khaled M, Zadicario E, et al. A pilot study of focused ultrasound thalamotomy for essential tremor. N Engl J Med 2013;369:640–8
   PubMed Web of Science ®Google Scholar
• Magara A, Buhler R, Moser D, Kowalski M, Pourtehrani P, Jeanmonod D. First experience with MR-guided focused ultrasound in the treatment of Parkinson’s disease. J Therapeut Ultrasound 2014;2:1–8
   PubMedGoogle Scholar
• Bing C, Ladouceur-Wodzak M, Wanner CR, Shelton JM, Richardson JA, Chopra R. Trans-cranial opening of the blood–brain barrier in targeted regions using a stereotaxic brain atlas and focused ultrasound energy. J Therapeut Ultrasound 2014;2:1–11
   PubMedGoogle Scholar
• Park EJ, Zhang YZ, Vykhodtseva N, McDannold N. Ultrasound-mediated blood–brain/blood–tumor barrier disruption improves outcomes with trastuzumab in a breast cancer brain metastasis model. J Control Release 2012;163:277–84
   PubMed Web of Science ®Google Scholar
• Alkins R, Burgess A, Ganguly M, Francia G, Kerbel R, Wels WS, et al. Focused ultrasound delivers targeted immune cells to metastatic brain tumors. Cancer Res 2013;73:1892–9
   PubMed Web of Science ®Google Scholar
• Liu HL, Hua MY, Chen PY, Chu PC, Pan CH, Yang HW, et al. Blood–brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment. Radiology 2010;255:415–25
   PubMed Web of Science ®Google Scholar
• Ting CY, Fan CH, Liu HL, Huang CY, Hsieh HY, Yen TC, et al. Concurrent blood–brain barrier opening and local drug delivery using drug-carrying microbubbles and focused ultrasound for brain glioma treatment. Biomaterials 2012;33:704–12
   PubMed Web of Science ®Google Scholar
• Liu HL, Hua MY, Yang HW, Huang CY, Chu PC, Wu JS, et al. Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain. Proc Natl Acad Sci USA 2010;107:15205–10
   PubMed Web of Science ®Google Scholar
• Treat LH, McDannold N, Vykhodtseva N, Zhang Y, Tam K, Hynynen K. Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound. Int J Cancer 2007;121:901–7
   PubMed Web of Science ®Google Scholar
• Treat LH, McDannold N, Zhang Y, Vykhodtseva N, Hynynen K. Improved anti-tumor effect of liposomal doxorubicin after targeted blood–brain barrier disruption by MRI-guided focused ultrasound in rat glioma. Ultrasound Med Biol 2012;38:1716–25
   PubMed Web of Science ®Google Scholar
• Aryal M, Vykhodtseva N, Zhang YZ, Park J, McDannold N. Multiple treatments with liposomal doxorubicin and ultrasound-induced disruption of blood–tumor and blood–brain barriers improve outcomes in a rat glioma model. J Control Release 2013;169:103–11
   PubMed Web of Science ®Google Scholar